Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer
Vered Stearns(Johns Hopkins University), Nancy E. Davidson(WinnMed), Susanne Briest(Leipzig University of Applied Sciences), Penny Powers(Parkland Health & Hospital System), Michaela J. Higgins(Cancer Trials Ireland), Edward Gabrielson(Johns Hopkins University), Calvin Chao(Johns Hopkins University), Elizabeth A. Sugar(Johns Hopkins University), Lisa K. Jacobs(Johns Hopkins University), Carl Yoshizawa(Einstein Medical Center Philadelphia), Theodore N. Tsangaris(Georgetown University), Saraswati Sukumar(Johns Hopkins University), Zandra Cheng(Johns Hopkins University), Julie R. Lange(Johns Hopkins Medicine), Stacie C. Jeter(Johns Hopkins University), Shannon A. Slater(Parkland Health & Hospital System), Igor Espinoza‐Delgado(National Institutes of Health), MaryJo Fackler(Johns Hopkins University), Michelle A. Rudek(Dana-Farber Cancer Institute)
Cited by 27
Related Papers
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k